A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues
Clinical trial NCT07057271 · COMPLETED
Trial details
- NCT number
- NCT07057271
- Sponsor
- Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2023-02-21
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.